Atossa Therapeutics, Inc. (ATOS): 10-Q filed Aug 7, 2026

Form type

10-Q

Filing date

Aug 7, 2026

Accession number

0001193125-26-339257

Filer

Atossa Therapeutics, Inc. (CIK 1488039)